Opinion: Hospitals must treat infection control as a priority, not a profit center
For years, hospitals penny-pinching on infection control has been an open secret. Whether Covid-19 will…
Author: STAT
Opinion: Structural racism is why I’m leaving organized psychiatry
The killings of George Floyd, Ahmaud Arbery, Breonna Taylor, and so many others are leading…
No one wants to go back to lockdown. Is there a middle ground for containing Covid-19?
First came the freezes. Governors last month started to “press pause” on the next phases…
An experiment in end-of-life care: Tapping AI’s cold calculus to nudge the most human of conversations
The daily email that arrived in physician Samantha Wang’s inbox at 8 a.m., just before…
STAT Plus: Indivior CEO pleads guilty in connection with a scheme to promote Suboxone
The chief executive of Indivior pleaded guilty to misbranding Suboxone Film, a medicine used to…
.jpg)
STAT Plus: Canadian court upholds most of a controversial new rule for controlling excessive drug prices
In a setback to the pharmaceutical industry, a federal court judge in Canada has dismissed…
U.S. could see 100,000 new Covid-19 cases per day, Fauci says
The United States may soon record as many as 100,000 new cases of Covid-19 a…
Opinion: Regeneron wasn’t making ‘kickbacks.’ It was helping people pay egregious Medicare copays
Last Wednesday, the Department of Justice filed suit against Regeneron for paying ” tens of…
STAT Plus: After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
U.K. officials and Vertex Pharmaceuticals (VRTX) have finally put to rest a years-long battle over…
STAT+ Conversations: The state of the pharmaceutical industry, featuring Pharmalot’s Ed Silverman
Editor’s note: A livestream of this conversation will be embedded below at 1 p.m. ET. …
Inovio claims positive results on Covid-19 vaccine but critical data are missing
Inovio Pharmaceuticals on Tuesday said that its investigational Covid-19 vaccine had “positive” results in a…
STAT Plus: Pharmalittle: FDA to issue guidance on Covid-19 vaccines; what remesdivir pricing may really mean
Top of the morning to you, and a fine one it is. A shiny sun…
Opinion: To make progress against Covid-19, processes must serve people, not a ‘labyrinth of bureaucratic rules’
By sheer necessity, the Covid-19 pandemic has united health care systems around the common purpose…
Opinion: Learning from Taiwan about responding to Covid-19 — and using electronic health records
Covid-19 is not an evenly distributed pandemic. The United States is an outlier — and…
A new FDA tool aims to inform cancer care, but experts say it has a glaring gap
A new Food and Drug Administration platform gives cancer patients and physicians a way to…
STAT Plus: The biotech scorecard for the third quarter: 14 stock-moving events to watch
Here is STAT’s Biotech Scorecard, our regular ledger of stock-moving biotech events, for the third…
In the Covid-19 death of a hospital food worker, a microcosm of the pandemic
This is one in a series of reports from hospitals responding to the Covid-19 pandemic. The hospital’s…
STAT Plus: Gilead’s pricing for remdesivir raises questions about the drug’s long-term prospects
After weeks of anticipation, Gilead Sciences (GILD) finally disclosed the pricing for its remdesivir experimental…
Researchers report nearly 300 cases of mysterious syndrome tied to Covid-19 in kids
Two U.S. research groups have reported finding nearly 300 cases of an alarming apparent side…
Opinion: What to expect from ‘Modernizing the FDA’s Data Strategy’ meeting
After being called off because of the Covid-19 pandemic, the FDA’s public meeting to discuss…
STAT Plus: How Gilead’s remdesivir price could come back to haunt the drug industry
Gilead Sciences, in a self-described effort to do “the right and responsible thing,” may have…
STAT Plus: Pharma trade group scolds AstraZeneca for bad behavior over an advisory board
A U.K. pharmaceutical industry trade group has publicly reprimanded AstraZeneca (AZN) for failing to uphold…
STAT Plus: Trouble in paradise: The Senate’s bipartisan accord on drug prices is broken, says Sen. Grassley
WASHINGTON — Sen. Chuck Grassley on Monday accused Democrats of walking away from negotiations on…
STAT Plus: Pharmalittle: Pharma giants plan $1 billion antibiotic venture; Gilead prices remdesivir below most estimates
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: FDA rejects Intercept Pharma’s drug for NASH
Intercept Pharmaceuticals said Monday that the Food and Drug Administration rejected its drug to treat…
Gilead announces long-awaited price for Covid-19 drug remdesivir
Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians,…
Opinion: An unsigned PDF blocks study participants from getting their own data needs to go
In the 1960s, Sherry Arnstein helped transform health care in the United States by leading…
Opinion: Medicare shouldn’t make ground ambulance services take a financial hit for providing at-home care
Ever since the coronavirus pandemic began sweeping across the U.S., ambulance crews have been treating…
New journal will vet Covid-19 preprints, calling out misinformation and highlighting credible research
The wild, wild west of Covid-19 preprints is about to get a new sheriff. On…
STAT Plus: Pharma giants to unveil major $1 billion venture to push novel antibiotics
Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1…
U.S. withdrawal from WHO threatens to leave it ‘flying blind’ on flu vaccines
Twice a year, influenza experts from 10 institutions around the world meet at the World…
Experts are calling for a 9/11-style commission on U.S. coronavirus response. Here’s where it could start
By the most basic of measurements — rates of illness and death — the U.S….
Two patients die in Audentes gene therapy study, heightening concerns over high-dose treatments
Two patients in a study of a high-dose gene therapy for a rare muscle disorder…
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
A form of CRISPR widely expected to be safer and possibly more effective that the…
STAT Plus: Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs
WASHINGTON — Pharmaceutical giant Pfizer is suing the Trump administration over two long-standing Medicare rules…
As Covid-19 cases surge, Pence touts progress made from earlier peaks
As criticism mounts that the White House has turned a blind eye to the worsening…
Opinion: Death threats, shoves, and throwing blood: Anti-vaxxers’ bullying of public health officials endangers our country
False claims. Racist and violent memes. Threats. Physical attacks. Public health advocates across the country…
STAT Plus: Pharmalittle: Sanofi to cut hundreds of jobs; former BARDA chief claims Azar is sabotaging his new job
And so, another working week will soon draw to a close. Not a moment too…
WHO, partners unveil ambitious plan to deliver 2 billion doses of Covid-19 vaccine to high-risk populations
The World Health Organization and key partners unveiled a plan Friday to purchase 2 billion…
Opinion: Unless it’s done carefully, the rise of telehealth could widen health disparities
The Covid-19 pandemic has pushed telehealth — the remote provision of health care resources, tools,…
Opinion: Covid-19 vaccine research must involve Black and Latinx participants
The development of a Covid-19 vaccine is progressing at an incredible pace, breaking down barriers…
Safer reopening will require millions more Covid-19 tests per day. One solution: ‘pool testing’
If the country wants to crank up its Covid-19 testing capacity into the millions —…
Watch: From nose to toe, the Covid-19 virus attacks like no other ‘respiratory’ infection
The reports seemed to take doctors by surprise: The “respiratory” virus that causes Covid-19 made…
STAT Plus: Zogenix wins approval for new drug to treat rare type of childhood epilepsy
A new drug from Zogenix that treats a rare and severe type of epilepsy was…
When Covid-19 hits the brain, it can cause strokes, psychosis and a dementia-like syndrome, new survey shows
A new survey reveals a wide range of serious psychiatric and neurological complications tied to…
Listen: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus
Is this a second wave or a rising tide? Who’s the real GlaxoSmithKline whistleblower? And…
Ousted federal vaccine expert alleges health secretary has continued to retaliate
WASHINGTON — Rick Bright, the ousted federal vaccine expert, amended his whistleblower complaint Thursday against…
As wave of Covid-19 cases crashes, a surge in other health conditions looms
The Covid-19 crisis has washed across the United States like a tidal wave. And experts…
STAT Plus: Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries
Novartis (NVS) agreed to pay more than $345 million to resolve criminal charges brought by…
CDC broadens guidance on Americans facing risk of severe Covid-19
The Centers for Disease Control and Prevention on Thursday broadened its warning about who is…